Article
Discovery of chromatin-based determinants of azacytidine and decitabine anti-cancer activity
2025-08-01
Abstract excerpt
The DNA-incorporating nucleoside analogs azacytidine (AZA) and decitabine (DEC) have clinical efficacy in blood cancers, yet the precise mechanism by which these agents kill cancer cells has remained unresolved -- specifically, whether their anti-tumor activity arises from conventional DNA damage or DNA hypomethylation via DNA methyltransferase 1 (DNMT1) inhibition. This incomplete mechanistic understanding has li...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c8dd79ea-b5ed-549f-a58d-df09da9c0890
- DOI
- 10.1101/2025.07.29.664810
